» Articles » PMID: 200224

The Effects of Amphiphilic Cationic Drugs and Inorganic Cations on the Activity of Phosphatidate Phosphohydrolase

Overview
Journal Biochem J
Specialty Biochemistry
Date 1977 Sep 1
PMID 200224
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

1. Phosphatidate phosphohydrolase from the particle-free supernatant of rat liver was assayed by using emulsions of phosphatidate as substrate. 2. The inhibition of the phosphohydrolase by chlorpromazine was of a competitive type with respect to phosphatidate. The potency of various amphiphilic cationic drugs as inhibitors of this reaction was related to their partition coefficients into a phosphatidate emulsion. 3. The effect of chlorpromazine on the phosphohydrolase activity was complementary rather than antagonistic towards Mg2+. Chlorpromazine stimulated the phosphohydrolase activity in the absence of added Mg2+ and was able to replace the requirement for Mg2+. However, at optimum concentrations of Mg2+, chlorpromazine inhibited the reaction, as did Ca2+. The phosphohydrolase activity was also stimulated by Co2+ and to a lesser extent by Mn2+, Fe2+, Fe3+, Ca2+, spermine and spermidine when Mg2+ was not added to the assays. 4. It is concluded that the inhibition of phosphatidate phosphohydrolase by amphiphilic cations can largely be explained by the interaction of these compounds with phosphatidate, which changes the physical properties of the lipid, making it less available for conversion into diacylglycerol. 5. The implications of these results to the effects of amphiphilic cations in redirecting glycerolipid synthesis at the level of phosphatidate are discussed.

Citing Articles

Short communication: Chlorpromazine causes a time-dependent decrease of lipids in .

Muhieddine D, Moughnie M, Abdel-Razzak Z Interdiscip Toxicol. 2020; 12(1):41-44.

PMID: 32189986 PMC: 7061449. DOI: 10.2478/intox-2019-0006.


Conserved residues in the N terminus of lipin-1 are required for binding to protein phosphatase-1c, nuclear translocation, and phosphatidate phosphatase activity.

Kok B, Skene-Arnold T, Ling J, Benesch M, Dewald J, Harris T J Biol Chem. 2014; 289(15):10876-10886.

PMID: 24558042 PMC: 4036199. DOI: 10.1074/jbc.M114.552612.


Phosphorylation of lipin 1 and charge on the phosphatidic acid head group control its phosphatidic acid phosphatase activity and membrane association.

Eaton J, Mullins G, Brindley D, Harris T J Biol Chem. 2013; 288(14):9933-9945.

PMID: 23426360 PMC: 3617293. DOI: 10.1074/jbc.M112.441493.


Regulation of cardiolipin biosynthesis in the heart.

Hatch G Mol Cell Biochem. 1996; 159(2):139-48.

PMID: 8858564 DOI: 10.1007/BF00420916.


Inhibition of LCAT in plasma from man and experimental animals by chlorpromazine.

Bell F, Hubert E Lipids. 1981; 16(11):815-9.

PMID: 7311740 DOI: 10.1007/BF02535035.


References
1.
Seydel J, Wassermann O . NMR-studies on the molecular basis of drug-induced phospholipidosis--II. Interaction between several amphiphilic drugs and phospholipids. Biochem Pharmacol. 1976; 25(21):2357-64. DOI: 10.1016/0006-2952(76)90028-9. View

2.
Lee A . Interactions between anaesthetics and lipid mixtures. Amines. Biochim Biophys Acta. 1976; 448(1):34-44. DOI: 10.1016/0005-2736(76)90074-2. View

3.
Dodds P, Gurr M, Brindley D . The glycerol phosphate, dihydroxyacetone phosphate and monoacylglycerol pathways of glycerolipid synthesis in rat adipose-tissue homogenates. Biochem J. 1976; 160(3):693-700. PMC: 1164287. DOI: 10.1042/bj1600693. View

4.
Brindley D, Bowley M, Burditt S, Pritchard H, BOUCROT P . The effects of administering N-(2-benzoyloxyethyl) norfenfluramine to rats on the hepatic synthesis of glycerolipids. J Pharm Pharmacol. 1976; 28(9):676-82. DOI: 10.1111/j.2042-7158.1976.tb02835.x. View

5.
Ragazzi M, Gorio A, Peluchetti D . Influence of calcium on the interaction of anesthetic drugs with artificial phospholipid membranes. Experientia. 1975; 31(5):567-8. DOI: 10.1007/BF01932462. View